132 related articles for article (PubMed ID: 7718156)
1. Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia.
Shinkai M; Suzuki M; Iijima S; Kobayashi T
Biotechnol Appl Biochem; 1995 Apr; 21(2):125-37. PubMed ID: 7718156
[TBL] [Abstract][Full Text] [Related]
2. Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes.
Shinkai M; Le B; Honda H; Yoshikawa K; Shimizu K; Saga S; Wakabayashi T; Yoshida J; Kobayashi T
Jpn J Cancer Res; 2001 Oct; 92(10):1138-45. PubMed ID: 11676866
[TBL] [Abstract][Full Text] [Related]
3. Thermosensitive gemcitabine-magnetoliposomes for combined hyperthermia and chemotherapy.
Ferreira RV; Martins TM; Goes AM; Fabris JD; Cavalcante LC; Outon LE; Domingues RZ
Nanotechnology; 2016 Feb; 27(8):085105. PubMed ID: 26820520
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of extruded magnetoliposomes.
Sabaté R; Barnadas-Rodríguez R; Callejas-Fernández J; Hidalgo-Alvarez R; Estelrich J
Int J Pharm; 2008 Jan; 347(1-2):156-62. PubMed ID: 17692483
[TBL] [Abstract][Full Text] [Related]
5. LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy.
Cepero A; Jiménez-Carretero M; Jabalera Y; Gago L; Luque C; Cabeza L; Melguizo C; Jimenez-Lopez C; Prados J
Int J Nanomedicine; 2024; 19():1843-1865. PubMed ID: 38414530
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characteristics of magnetite-labelled antibody with the use of poly(ethylene glycol) derivatives.
Suzuki M; Shinkai M; Kamihira M; Kobayashi T
Biotechnol Appl Biochem; 1995 Jun; 21(3):335-45. PubMed ID: 7794535
[TBL] [Abstract][Full Text] [Related]
7. Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer.
Clares B; Biedma-Ortiz RA; Sáez-Fernández E; Prados JC; Melguizo C; Cabeza L; Ortiz R; Arias JL
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):329-38. PubMed ID: 23485475
[TBL] [Abstract][Full Text] [Related]
8. Functional magnetic particles for medical application.
Shinkai M; Ito A
Adv Biochem Eng Biotechnol; 2004; 91():191-220. PubMed ID: 15453197
[TBL] [Abstract][Full Text] [Related]
9. The effect of superparamagnetic iron oxide nanoparticles surface engineering on relaxivity of magnetoliposome.
Khaleghi S; Rahbarizadeh F; Ahmadvand D; Malek M; Madaah Hosseini HR
Contrast Media Mol Imaging; 2016 Sep; 11(5):340-349. PubMed ID: 27307214
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of chemohyperthermia with docetaxel-embedded magnetoliposomes as minimally invasive local treatment for cancer.
Yoshida M; Watanabe Y; Sato M; Maehara T; Aono H; Naohara T; Hirazawa H; Horiuchi A; Yukumi S; Sato K; Nakagawa H; Yamamoto Y; Sugishita H; Kawachi K
Int J Cancer; 2010 Apr; 126(8):1955-1965. PubMed ID: 19711342
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors.
Cerdan S; Lötscher HR; Künnecke B; Seelig J
Magn Reson Med; 1989 Nov; 12(2):151-63. PubMed ID: 2615625
[TBL] [Abstract][Full Text] [Related]
12. Solid and aqueous magnetoliposomes as nanocarriers for a new potential drug active against breast cancer.
Rodrigues ARO; Mendes PMF; Silva PML; Machado VA; Almeida BG; Araújo JP; Queiroz MRP; Castanheira EMS; Coutinho PJG
Colloids Surf B Biointerfaces; 2017 Oct; 158():460-468. PubMed ID: 28732311
[TBL] [Abstract][Full Text] [Related]
13. Development of a target-directed magnetic resonance contrast agent using monoclonal antibody-conjugated magnetic particles.
Suzuki M; Honda H; Kobayashi T; Wakabayashi T; Yoshida J; Takahashi M
Noshuyo Byori; 1996 Nov; 13(2):127-32. PubMed ID: 8958518
[TBL] [Abstract][Full Text] [Related]
14. Magnetoliposomes of mixed biomimetic and inorganic magnetic nanoparticles as enhanced hyperthermia agents.
Jabalera Y; Fernández-Vivas A; Iglesias GR; Delgado ÁV; Jimenez-Lopez C
Colloids Surf B Biointerfaces; 2019 Nov; 183():110435. PubMed ID: 31430636
[TBL] [Abstract][Full Text] [Related]
15. Stable long-term intracellular labelling with fluorescently tagged cationic magnetoliposomes.
Soenen SJ; Vercauteren D; Braeckmans K; Noppe W; De Smedt S; De Cuyper M
Chembiochem; 2009 Jan; 10(2):257-67. PubMed ID: 19072823
[TBL] [Abstract][Full Text] [Related]
16. A study on the thermochemotherapy effect of nanosized As2O3/MZF thermosensitive magnetoliposomes on experimental hepatoma in vitro and in vivo.
Wang L; Zhang J; An Y; Wang Z; Liu J; Li Y; Zhang D
Nanotechnology; 2011 Aug; 22(31):315102. PubMed ID: 21730756
[TBL] [Abstract][Full Text] [Related]
17. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study.
Shinkai M; Yanase M; Honda H; Wakabayashi T; Yoshida J; Kobayashi T
Jpn J Cancer Res; 1996 Nov; 87(11):1179-83. PubMed ID: 9045948
[TBL] [Abstract][Full Text] [Related]
18. Characterization and cytotoxicity studies on liposome-hydrophobic magnetite hybrid colloids.
Floris A; Sinico C; Fadda AM; Lai F; Marongiu F; Scano A; Pilloni M; Angius F; Vázquez-Vázquez C; Ennas G
J Colloid Interface Sci; 2014 Jul; 425():118-27. PubMed ID: 24776672
[TBL] [Abstract][Full Text] [Related]
19. Adsorption of antiphospholipid antibodies on affinity magnetoliposomes.
de Pinho SC; Zollner RL; De Cuyper M; Santana MH
Colloids Surf B Biointerfaces; 2008 Jun; 63(2):249-53. PubMed ID: 18243670
[TBL] [Abstract][Full Text] [Related]
20. Applications of magnetoliposomes with encapsulated doxorubicin for integrated chemotherapy and hyperthermia of rat C6 glioma.
Babincová N; Sourivong P; Babinec P; Bergemann C; Babincová M; Durdík Š
Z Naturforsch C J Biosci; 2018 Jul; 73(7-8):265-271. PubMed ID: 29894307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
